LVZ Inc. Grows Stock Holdings in Stryker Corporation $SYK

LVZ Inc. increased its stake in shares of Stryker Corporation (NYSE:SYK) by 3.7% during the second quarter, Holdings Channel reports. The institutional investor owned 4,399 shares of the medical technology company’s stock after acquiring an additional 156 shares during the period. LVZ Inc.’s holdings in Stryker were worth $1,740,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Covea Finance raised its position in Stryker by 92.8% during the second quarter. Covea Finance now owns 26,034 shares of the medical technology company’s stock worth $10,300,000 after acquiring an additional 12,534 shares during the last quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO raised its position in Stryker by 14.4% during the second quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 9,437 shares of the medical technology company’s stock worth $3,734,000 after acquiring an additional 1,191 shares during the last quarter. Kwmg LLC raised its position in Stryker by 4.2% during the second quarter. Kwmg LLC now owns 1,407 shares of the medical technology company’s stock worth $557,000 after acquiring an additional 57 shares during the last quarter. Martin Capital Advisors LLP raised its position in Stryker by 6.0% during the second quarter. Martin Capital Advisors LLP now owns 2,807 shares of the medical technology company’s stock worth $1,111,000 after acquiring an additional 160 shares during the last quarter. Finally, Crew Capital Management Ltd. acquired a new position in Stryker during the second quarter worth about $1,065,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insiders Place Their Bets

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the transaction, the director directly owned 3,222,108 shares in the company, valued at $1,212,962,556.60. This represents a 5.84% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Viju Menon sold 500 shares of the stock in a transaction on Monday, August 25th. The shares were sold at an average price of $390.61, for a total transaction of $195,305.00. Following the transaction, the insider owned 12,511 shares in the company, valued at $4,886,921.71. This trade represents a 3.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 5.20% of the company’s stock.

Stryker Price Performance

Shares of SYK stock opened at $378.70 on Tuesday. The company has a market capitalization of $144.78 billion, a PE ratio of 50.16, a price-to-earnings-growth ratio of 2.71 and a beta of 0.93. The firm has a fifty day simple moving average of $387.26 and a 200-day simple moving average of $379.05. The company has a current ratio of 1.78, a quick ratio of 1.06 and a debt-to-equity ratio of 0.70. Stryker Corporation has a twelve month low of $329.16 and a twelve month high of $406.19.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, beating the consensus estimate of $3.07 by $0.06. The business had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $5.92 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.81 earnings per share. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Equities research analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker’s dividend payout ratio is 44.50%.

Analyst Upgrades and Downgrades

SYK has been the subject of a number of research reports. Wall Street Zen upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research report on Friday, July 18th. Rothschild Redb raised shares of Stryker to a “hold” rating in a research report on Thursday, September 18th. BTIG Research reissued a “buy” rating on shares of Stryker in a research report on Monday, July 14th. Truist Financial set a $415.00 price objective on shares of Stryker and gave the company a “hold” rating in a research report on Monday, August 4th. Finally, Rothschild & Co Redburn assumed coverage on shares of Stryker in a research report on Thursday, September 18th. They issued a “neutral” rating and a $420.00 price objective for the company. Fourteen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $430.33.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.